Fingerprint
Dive into the research topics of 'Phase I study of low-dose cyclophosphamide and recombinant interleukin-2 for the treatment of advanced cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I study of low-dose cyclophosphamide and recombinant interleukin-2 for the treatment of advanced cancer
Christopher J. Verdi, Charles W. Taylor, Marilyn K. Croghan, Patricia Dalke, Frank L. Meyskens, Evan M. Hersh
Research output: Contribution to journal › Article › peer-review
17
Scopus
citations